Kestra Advisory Services LLC lifted its position in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 96.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 110,985 shares of the real estate investment trust’s stock after acquiring an additional 54,436 shares during the period. Kestra Advisory Services LLC’s holdings in Healthpeak Properties were worth $1,823,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in DOC. Integrated Wealth Concepts LLC grew its position in shares of Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after buying an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP boosted its stake in Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after acquiring an additional 17,279 shares in the last quarter. Brown Advisory Inc. boosted its stake in Healthpeak Properties by 3.1% during the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after acquiring an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd purchased a new stake in Healthpeak Properties in the second quarter worth about $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Trading Down 1.0%
Shares of NYSE:DOC opened at $22.27 on Tuesday. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.72. The company has a market cap of $15.36 billion, a P/E ratio of 69.61, a PEG ratio of 3.50 and a beta of 1.02. The stock’s fifty day moving average price is $20.52 and its 200-day moving average price is $18.30.
Healthpeak Properties Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.5%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.
Insider Activity at Healthpeak Properties
In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.23% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of equities analysts have weighed in on DOC shares. Barclays assumed coverage on shares of Healthpeak Properties in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 target price for the company. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Wells Fargo & Company upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. Raymond James Financial initiated coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating for the company. Finally, UBS Group lifted their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and an average price target of $20.62.
Get Our Latest Research Report on DOC
Healthpeak Properties Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
